Conferences and Talks

---

VCS 2025, Salt Lake City

New genomic insights and emerging therapeutic opportunities in hemangiosarcoma revealed by comprehensive genomic profiling
At the VCS 2025 Annual Conference in Salt Lake City, Dr. Guannan Wang presented new genomic insights and emerging therapeutic opportunities in hemangiosarcoma, uncovered through comprehensive genomic profiling with Canine CGP, along with preliminary but promising outcome data. We are committed to letting high-quality data and collaboration drive progress against this devastating disease and many other cancers that impact the lives of our beloved pets.

---

ESVP- ECVP Congress 2025

Comprehensive Genomic Profiling for Canine Cancers: VetOmics’ Approach to Precision Medicine
At the ESVP-ECVP 2025 Congress, Dr. Guannan Wang presented VetOmics’ mission to advance precision medicine in veterinary oncology through innovative solutions and interdisciplinary collaboration. Dr. Wang shared the latest performance metrics of the Canine CGP test, highlighting its robust data, strong real-world clinical impact and expanding therapeutic and diagnostic applications. Canine CGP is helping transform precision oncology for pets and driving the adoption of evidence-based, personalized cancer care.

---

VCS 2024

At VCS 2024, VetOmics officially launched its comprehensive genomic diagnostic service for veterinary oncology, ushering in a new era of precision medicine for pets with cancer.

---